System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Frédéric Lapostolle, MD, PhD is an expert in Critical care at Hôpital Avicenne (France). Frédéric Lapostolle has authored 404 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 3 of them ongoing. SLR score: 1,439 (community average: 125). How the SLR is computed.

LeadR Profile

Frédéric Lapostolle, MD, PhD Hôpital Avicenne France
1 439 ScienceLeadR Reputation 1439

Unlock

Register Login
Network Map

Critical care

Subspecialties: Public Health - Cardiology - Geriatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Hôpital Avicenne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 404

Citations

Citations: 11 011 1st author: 116 Last author: 112 Unique author: 1

Main journals

Resuscitation 31
Presse Med 30
Eur J Emerg Med 25
Ann Fr Anesth Reanim 20
Am J Emerg Med 18

Best Journals

N Engl J Med 6
JAMA 3
Circulation 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Vasopressor use after return of spontaneous circulation after out-hospital cardiac arrest: the CARACAS study.
PMID 42949589 — emergencies, emergency medicine, heart arrest, return of spontaneous circulation		Eur J Emerg Med20260
Association of calculated weight-indexed first-bolus epinephrine with outcomes after out-of-hospital cardiac arrest: EPIKILO study.
PMID 42926185 — emergency medicine, out-of-hospital cardiac arrest, epinephrine, heart arrest		Am J Emerg Med20260
Early complications related to acute myocardial infarction: evolution over 20 years and risk factors. The ECAMI study.
PMID 41251933 — mortality, myocardial infarction, incidence, internal medicine, hospital mortality, st elevation myocardial infarction, reaction time, risk factors		Intern Emerg Med20250
Incidence of hypothermia in trauma patients in tropical environments: the HypoTrop Study.
PMID 42659634 — incidence, emergencies, emergency medicine, hypothermia, environment, wounds and injuries		Eur J Emerg Med20260
Chlordecone (Kepone) exposure in the French West Indies: the urgent need to address a flawed management approach.
PMID 42469018 — environmental exposure, occupational health, chlordecone, environmental health		Occup Environ Med20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 9
Phase 4 7
N/A 5

By status:

Completed 12
Terminated 3
Unknown 3
Active not recruiting 1
Not yet recruiting 1
Recruiting 1

By type:

Interventional 21

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 0
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Use of the Methoxyflurane as Pain killer in the Prehospital Management of Acute Myocardial Infarction
NCT07445737 — morphine, myocardial infarction, pain, self administration, methoxyflurane, st elevation myocardial infarction, analgesics, therapeutics, chest pain		Phase 3Not yet recruiting2026
Optimisation Strategy for Emergency Tracheal Intubation
NCT05539391 — arterial pressure, rocuronium, laryngoscopy, intubation, emergencies, heart rate, heart, rapid sequence induction and intubation, masks, succinylcholine, physical examination, gingiva, restraint, physical, morbidity, ventilation, history, oxygen saturation		N/ARecruiting2023
A Phase 3 Study of Zalunfiban in Subjects With ST elevation MI
NCT04825743 — injections, safety, myocardial infarction, ambulances, st elevation myocardial infarction, therapeutics, blood platelets, injections, subcutaneous, small molecules		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS